United Arab Emirates Next Generation Sequencing (NGS) Market to 2032
Overview
The United Arab Emirates Next Generation Sequencing (NGS) Market is expected to reach a 521.73 USD Billion by 2032 and is projected to grow at a CAGR of 15.80% from 2025 to 2032.
United Arab Emirates Next Generation Sequencing (NGS) Market 2018-2032 USD Billion
United Arab Emirates Next Generation Sequencing (NGS) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 219.36 USD Billion
- Projected Market Size (2032): 521.73 USD Billion
- CAGR (2025-2032): 15.80%
Key Findings of United Arab Emirates Next Generation Sequencing (NGS) Market
- The United Arab Emirates Next Generation Sequencing (NGS) Market was valued at 521.73 USD Billion in 2024.
- The United Arab Emirates Next Generation Sequencing (NGS) Market is likely to grow at a CAGR of 15.80% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Pharmaceuticals Microbiology in Application Segment accounted for the largest share of the market with a revenue of 224.39 USD Billion
- The fastest growing segment Services in Product & Service Segment grew Fastest with a CAGR of 17.44% during the forecast period from 2024 to 2032.
United Arab Emirates Next Generation Sequencing (NGS) Market Scope
- Instruments
- Services
- Consumables
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Drug & Biomarker Discovery
- Precision Medicine
- Pharmaceuticals Microbiology
- Others
- Retail Sales
- Direct Tender
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
United Arab Emirates Next Generation Sequencing (NGS) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 219.36 USD Billion |
| Market Value in 2032 | 521.73 USD Billion |
| CAGR (2025-2032) | 15.80% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product & Service,Technology,Application,Distribution Channel,End User |
Regional Insights:
-
Leading Market (2024-2032): United Arab Emirates, leading in terms of revenue 219.36 USD Billion in 2024
- Key Country: United Arab Emirates, leading in terms of revenue with value of 219.36 USD Billion in 2024.
Segments and Scope
-
United Arab Emirates Next Generation Sequencing (NGS) Market to 2032, By Product & Service
- Consumables is the largest segment in United Arab Emirates Next Generation Sequencing (NGS) Market to 2032 with a revenue of 145.38 USD Billion in the year 2024.
- Services is the Fastest growing segment in United Arab Emirates Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 15.46 % in forecast period 2025-2032.
-
United Arab Emirates Next Generation Sequencing (NGS) Market to 2032, By Technology
- Sequencing By Synthesis (SBS) is the largest segment in United Arab Emirates Next Generation Sequencing (NGS) Market to 2032 with a revenue of 161.24 USD Billion in the year 2024.
- Sequencing By Synthesis (SBS) is the Fastest growing segment in United Arab Emirates Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 15.88 % in forecast period 2025-2032.
-
United Arab Emirates Next Generation Sequencing (NGS) Market to 2032, By Application
- Pharmaceuticals Microbiology is the largest segment in United Arab Emirates Next Generation Sequencing (NGS) Market to 2032 with a revenue of 224.39 USD Billion in the year 2024.
- Pharmaceuticals Microbiology is the Fastest growing segment in United Arab Emirates Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 16.25 % in forecast period 2025-2032.
-
United Arab Emirates Next Generation Sequencing (NGS) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in United Arab Emirates Next Generation Sequencing (NGS) Market to 2032 with a revenue of 160.68 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in United Arab Emirates Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 15.90 % in forecast period 2025-2032.
-
United Arab Emirates Next Generation Sequencing (NGS) Market to 2032, By End User
- Pharmaceutical & Biotechnology Companies is the largest segment in United Arab Emirates Next Generation Sequencing (NGS) Market to 2032 with a revenue of 129.18 USD Billion in the year 2024.
- Pharmaceutical & Biotechnology Companies is the Fastest growing segment in United Arab Emirates Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 16.13 % in forecast period 2025-2032.
United Arab Emirates Next Generation Sequencing (NGS) Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Charles River Laboratories | |||
United Arab Emirates Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion
United Arab Emirates Next Generation Sequencing (NGS) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Coming Soon....
United Arab Emirates Next Generation Sequencing (NGS) Market Scope
- Instruments
- Services
- Consumables
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Drug & Biomarker Discovery
- Precision Medicine
- Pharmaceuticals Microbiology
- Others
- Retail Sales
- Direct Tender
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Frequently Asked Questions
United Arab Emirates Next Generation Sequencing (NGS) Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.